CRISPR Therapeutics Stock Is Up Only 8% This Year. Is Cathie Wood's Bet on the Gene-Editing Stock Dead Money?
CRISPR Therapeutics (NASDAQ: CRSP) is up only slightly more than 8% so far this year, well under the 27% return of the Nasdaq Biotechnology index and slightly below the 12% return of the S&P 500. That’s not particularly surprising, since the biotechnology company has one commercialized therapy and has never shown a profit.
3 Ways to Invest in Cybersecurity Through ETFs
Key Points
-
Interested in Global X Cybersecurity ETF? Here are five stocks we like better.
-
Cybersecurity ETFs may look similar at first glance, but their portfolio construction can lead to very different results.
-
Global X Cybersecurity ETF,
» Read more about: 3 Ways to Invest in Cybersecurity Through ETFs »
Read MoreDow, S&P 500 and Nasdaq open higher as Treasury selloff eases
All three major US indices opened in the green on Tuesday as a cooling Treasury selloff gave equity markets room to breathe. The S&P 500 climbed roughly 0.2% to around 7,708, the Dow Jones Industrial Average added about 120 points to reach approximately 53,463, and the Nasdaq followed suit with modest gains.
The catalyst: the US Treasury Department announced plans to at least double its buybacks of longer-term Treasury bonds,
» Read more about: Dow, S&P 500 and Nasdaq open higher as Treasury selloff eases »
Read MoreUBS Boosts S&P 500 Forecast to 8,100 with Bull Run Expected Through 2027
Key Takeaways
- UBS Global Wealth Management increased its year-end S&P 500 forecast to 8,100 from an earlier projection
- This revised target suggests approximately 6% potential gains from Thursday’s 7,641 closing level
- The firm boosted its S&P 500 earnings per share projections to $350 for 2026 and $400 for 2027
- UBS also elevated its mid-2027 benchmark target to 8,400
- Three core factors underpin the optimistic outlook: solid economic expansion,
» Read more about: UBS Boosts S&P 500 Forecast to 8,100 with Bull Run Expected Through 2027 »
Read MoreMarket Movers: Nvidia (NVDA) Earnings Loom as Dick’s Sporting Goods (DKS) Plunges 27%
Key Highlights
- Shares of Dick’s Sporting Goods plummeted approximately 27% following a significant reduction in annual revenue and profit projections
- Nvidia’s quarterly report on Wednesday could trigger a market valuation swing approaching $280 billion
- Advanced Micro Devices climbed 3-4% following a favorable analyst revision as semiconductor stocks regained momentum
- Alibaba leadership,
The Burst
Champion Trader vs Cathie Wood: Who Wins?
A battle between a great trader and a prominent money manager has taken place in recent years. Mark Minervini, 2x US trading champion, has taken shots at billion dollar money manager, Cathie Wood of ARK Invest.
His primary critique appears to be based in a rule that he has observed over time. A stock that has fallen 80% can decline by another 50%.
» Read more about: Champion Trader vs Cathie Wood: Who Wins? »
Read MoreThe Ivy
66% Upside In Asian Ride-sharing Stock?
Grab Holdings has evolved into Southeast Asia’s leading super-app with operations spanning ride-hailing, food/grocery delivery, and financial services.
Growth momentum has been strong, particularly since 2023 which was a pivotal year when Grab hit its first quarterly profit. That took place in Q4 2023 on $653 million revenue, up 30% year-on-year.
Under the hood,
» Read more about: 66% Upside In Asian Ride-sharing Stock? »
Read MoreThe Spotlight
Market Commentary: 1 Dividend Stock To Turn $35,000 Into $100,000
When you go hunting for dividend-paying stocks, a tenured growth streak offers a lot of confidence that the company can sustain its payout to shareholders. One stock that fits that bill is Enterprise Products Partners, a midstream energy company that offers a mouth-watering 7.44% dividend.
Key Points
- EPD is a monster cash producer,
» Read more about: Market Commentary: 1 Dividend Stock To Turn $35,000 Into $100,000 »